Host transcriptional signatures predict etiology in community-acquired pneumonia: Potential antibiotic stewardship tools

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Host transcriptional signatures predict etiology in community-acquired pneumonia: Potential antibiotic stewardship tools. / Siljan, William W; Sivakumaran, Dhanasekaran; Ritz, Christian; Jenum, Synne; Ottenhoff, Tom Hm; Ulvestad, Elling; Holter, Jan C; Heggelund, Lars; Grewal, Harleen MS.

In: Biomarker Insights, Vol. 17, No. January-December, 2022, p. 1-8.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Siljan, WW, Sivakumaran, D, Ritz, C, Jenum, S, Ottenhoff, TH, Ulvestad, E, Holter, JC, Heggelund, L & Grewal, HMS 2022, 'Host transcriptional signatures predict etiology in community-acquired pneumonia: Potential antibiotic stewardship tools', Biomarker Insights, vol. 17, no. January-December, pp. 1-8. https://doi.org/10.1177/11772719221099130

APA

Siljan, W. W., Sivakumaran, D., Ritz, C., Jenum, S., Ottenhoff, T. H., Ulvestad, E., Holter, J. C., Heggelund, L., & Grewal, H. MS. (2022). Host transcriptional signatures predict etiology in community-acquired pneumonia: Potential antibiotic stewardship tools. Biomarker Insights, 17(January-December), 1-8. https://doi.org/10.1177/11772719221099130

Vancouver

Siljan WW, Sivakumaran D, Ritz C, Jenum S, Ottenhoff TH, Ulvestad E et al. Host transcriptional signatures predict etiology in community-acquired pneumonia: Potential antibiotic stewardship tools. Biomarker Insights. 2022;17(January-December):1-8. https://doi.org/10.1177/11772719221099130

Author

Siljan, William W ; Sivakumaran, Dhanasekaran ; Ritz, Christian ; Jenum, Synne ; Ottenhoff, Tom Hm ; Ulvestad, Elling ; Holter, Jan C ; Heggelund, Lars ; Grewal, Harleen MS. / Host transcriptional signatures predict etiology in community-acquired pneumonia: Potential antibiotic stewardship tools. In: Biomarker Insights. 2022 ; Vol. 17, No. January-December. pp. 1-8.

Bibtex

@article{28794ef82cfb45ac9ac0ab390c0fac93,
title = "Host transcriptional signatures predict etiology in community-acquired pneumonia: Potential antibiotic stewardship tools",
abstract = "Background: Current approaches for pathogen identification in community-acquired pneumonia (CAP) remain suboptimal, leaving most patients without a microbiological diagnosis. If better diagnostic tools were available for differentiating between viral and bacterial CAP, unnecessary antibacterial therapy could be avoided in viral CAP patients.Methods: In 156 adults hospitalized with CAP classified to have bacterial, viral, or mixed viral-bacterial infection based on microbiological testing or both microbiological testing and procalcitonin (PCT) levels, we aimed to identify discriminatory host transcriptional signatures in peripheral blood samples acquired at hospital admission, by applying Dual-color-Reverse-Transcriptase-Multiplex-Ligation-dependent-Probe-Amplification (dc-RT MLPA).Results: In patients classified by microbiological testing, a 9-transcript signature showed high accuracy for discriminating bacterial from viral CAP (AUC 0.91, 95% CI 0.85-0.96), while a 10-transcript signature similarly discriminated mixed viral-bacterial from viral CAP (AUC 0.91, 95% CI 0.86-0.96). In patients classified by both microbiological testing and PCT levels, a 13-transcript signature showed excellent accuracy for discriminating bacterial from viral CAP (AUC 1.00, 95% CI 1.00-1.00), while a 7-transcript signature similarly discriminated mixed viral-bacterial from viral CAP (AUC 0.93, 95% CI 0.87-0.98).Conclusion: Our findings support host transcriptional signatures in peripheral blood samples as a potential tool for guiding clinical decision-making and antibiotic stewardship in CAP.",
keywords = "Faculty of Science, Pneumonia, Gene expression signatures, Bacteria, Viruses, Antimicrobial stewardship, Clinical decision-making",
author = "Siljan, {William W} and Dhanasekaran Sivakumaran and Christian Ritz and Synne Jenum and Ottenhoff, {Tom Hm} and Elling Ulvestad and Holter, {Jan C} and Lars Heggelund and Grewal, {Harleen MS}",
note = "{\textcopyright} The Author(s) 2022.",
year = "2022",
doi = "10.1177/11772719221099130",
language = "English",
volume = "17",
pages = "1--8",
journal = "Biomarker Insights",
issn = "1177-2719",
publisher = "Libertas Academica Ltd.",
number = "January-December",

}

RIS

TY - JOUR

T1 - Host transcriptional signatures predict etiology in community-acquired pneumonia: Potential antibiotic stewardship tools

AU - Siljan, William W

AU - Sivakumaran, Dhanasekaran

AU - Ritz, Christian

AU - Jenum, Synne

AU - Ottenhoff, Tom Hm

AU - Ulvestad, Elling

AU - Holter, Jan C

AU - Heggelund, Lars

AU - Grewal, Harleen MS

N1 - © The Author(s) 2022.

PY - 2022

Y1 - 2022

N2 - Background: Current approaches for pathogen identification in community-acquired pneumonia (CAP) remain suboptimal, leaving most patients without a microbiological diagnosis. If better diagnostic tools were available for differentiating between viral and bacterial CAP, unnecessary antibacterial therapy could be avoided in viral CAP patients.Methods: In 156 adults hospitalized with CAP classified to have bacterial, viral, or mixed viral-bacterial infection based on microbiological testing or both microbiological testing and procalcitonin (PCT) levels, we aimed to identify discriminatory host transcriptional signatures in peripheral blood samples acquired at hospital admission, by applying Dual-color-Reverse-Transcriptase-Multiplex-Ligation-dependent-Probe-Amplification (dc-RT MLPA).Results: In patients classified by microbiological testing, a 9-transcript signature showed high accuracy for discriminating bacterial from viral CAP (AUC 0.91, 95% CI 0.85-0.96), while a 10-transcript signature similarly discriminated mixed viral-bacterial from viral CAP (AUC 0.91, 95% CI 0.86-0.96). In patients classified by both microbiological testing and PCT levels, a 13-transcript signature showed excellent accuracy for discriminating bacterial from viral CAP (AUC 1.00, 95% CI 1.00-1.00), while a 7-transcript signature similarly discriminated mixed viral-bacterial from viral CAP (AUC 0.93, 95% CI 0.87-0.98).Conclusion: Our findings support host transcriptional signatures in peripheral blood samples as a potential tool for guiding clinical decision-making and antibiotic stewardship in CAP.

AB - Background: Current approaches for pathogen identification in community-acquired pneumonia (CAP) remain suboptimal, leaving most patients without a microbiological diagnosis. If better diagnostic tools were available for differentiating between viral and bacterial CAP, unnecessary antibacterial therapy could be avoided in viral CAP patients.Methods: In 156 adults hospitalized with CAP classified to have bacterial, viral, or mixed viral-bacterial infection based on microbiological testing or both microbiological testing and procalcitonin (PCT) levels, we aimed to identify discriminatory host transcriptional signatures in peripheral blood samples acquired at hospital admission, by applying Dual-color-Reverse-Transcriptase-Multiplex-Ligation-dependent-Probe-Amplification (dc-RT MLPA).Results: In patients classified by microbiological testing, a 9-transcript signature showed high accuracy for discriminating bacterial from viral CAP (AUC 0.91, 95% CI 0.85-0.96), while a 10-transcript signature similarly discriminated mixed viral-bacterial from viral CAP (AUC 0.91, 95% CI 0.86-0.96). In patients classified by both microbiological testing and PCT levels, a 13-transcript signature showed excellent accuracy for discriminating bacterial from viral CAP (AUC 1.00, 95% CI 1.00-1.00), while a 7-transcript signature similarly discriminated mixed viral-bacterial from viral CAP (AUC 0.93, 95% CI 0.87-0.98).Conclusion: Our findings support host transcriptional signatures in peripheral blood samples as a potential tool for guiding clinical decision-making and antibiotic stewardship in CAP.

KW - Faculty of Science

KW - Pneumonia

KW - Gene expression signatures

KW - Bacteria

KW - Viruses

KW - Antimicrobial stewardship

KW - Clinical decision-making

U2 - 10.1177/11772719221099130

DO - 10.1177/11772719221099130

M3 - Journal article

C2 - 35693251

VL - 17

SP - 1

EP - 8

JO - Biomarker Insights

JF - Biomarker Insights

SN - 1177-2719

IS - January-December

ER -

ID: 310222190